Read More Pharma Industry News ABIONYX Pharma (ABNX) achieves sphingomyelin manufacturing breakthrough to advance CER-001 sepsis program ABIONYX Pharma triples CER-001 sphingomyelin yield with proprietary synthesis, advancing its sepsis programme. Read the full strategic analysis. byVenkateshMarch 27, 2026